We are engaged for
SHARING
Funding DISRUPTIVE Brain Research
STRATEGY
Co-investing alongside leading PE managers in leveraged buyout LBO transactions.
Through a disciplined co-investment approach, the strategy seeks to deliver strong risk-adjusted returns.
- Co-investment in LBO transactions alongside top-tier PE sponsors
- No fees, no carry
- A transparent profit-sharing model between investors and medical research
A unique 80/20 philantropic model
- The Brain Fund is structured to maximize its scientific impact.
- 80% of capital gains are donated to the Paris Brain Institute, supporting groundbreaking research in neuroscience.
- 20% of capital gains are distributed to investors.
This model allows investors to participate in PE investments while helping accelerate research on neurological and psychiatric diseases.
